First Solar FSLR
Energy · Solar · Synthos Deep Dive · 2026-07-03
The Overview
First Solar makes solar panels — the big glass modules that sit on solar farms. It's the biggest American panel maker, and importantly it does not rely on Chinese supply chains, which matters a lot to US utilities and to US policy.
The good news: the stock is cheap. You're paying about $14 for every $1 the company earns (that's low — a typical stock is $20-25), the company has more cash than debt, and it has already sold 47.9 gigawatts of future panels under contract. The catch: a big chunk of its profit comes from a US government tax credit for making panels in America. If Washington cuts that credit, profits drop hard. On top of that, this is a boom-and-bust industry — the stock swings much more than the market, and it has just fallen 29% from its high.
Our verdict is Buy — Tactical: a decent bet at a cheap, beaten-down price, but treat it as a trade to size small, not a set-and-forget nest-egg holding.
Here's what our three scores mean in everyday terms:
- Downside Risk 6/10 (a bit above average). The balance sheet is rock-solid and the stock is cheap, but it swings hard and leans on a government subsidy — so it can fall a long way fast.
- Growth Quality 7/10 (good). Sales and profits are genuinely growing and margins are healthy — but those margins depend partly on the subsidy, not purely on the product.
- Exponential Potential 5/10 (moderate). Solar demand is real and large, but this is a commodity-panel maker in a cyclical industry — not the kind of business that compounds relentlessly.
The one big worry: the government manufacturing tax credit. It is roughly 40% of the profit the company guides to this year. Any change in Washington's policy is the single thing that could break this story.
Putting a number on it: our fair-value estimate is $260 against a current price of $204.46 — real upside if our numbers are right.
Our summary metrics
Fortress net-cash balance sheet & 14× earnings, but beta 1.7, deep cyclicality, and a policy-dependent 45X tax credit that is ~40% of EBITDA.
~14% forward EPS CAGR, 42% gross margin, 18% ROE, 47.9 GW backlog — but margins hinge on subsidies, not just product.
Real US-demand tailwind and TAM, but a cyclical commodity module maker at a policy-driven inflection, not a compounding platform.
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Exponential Potential
Real US-demand tailwind and TAM, but a cyclical commodity module maker at a policy-driven inflection, not a compounding platform.
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $255 (high $315 / low $205; 44 Buy · 22 Hold · 7 Sell) — context, not our anchor |
| Valuation | 14.5× trailing EPS · 12.7× FY26E · 9.3× FY27E · 8.3× FY30E · EV/S 4.1× · EV/EBITDA 9.6× |
| Technicals | Downtrend / oversold — $224.6, −29% off 52-wk high, below 50/200-DMA, RSI 22, MACD negative; +38% 12-mo still beats SPY +21% |
| Conviction | Low — 0 net-bullish voices, 0 traceable claims; this is a quant/fundamentals call, not an expert-panel call |
| Position sizing | Tactical / satellite, ~1–3% — a cyclical trade, not a core compounder |
What the experts actually said 1 traceable claims on FSLR · showing the highest-conviction voices
“First Solar's 'American-made, China-independent' narrative is illusory — its cadmium-telluride tech is effectively single-sourced on tellurium, whose production China controls, so the choke-point dependency persists.”
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $204.46, 9% below the 50-day average ($224), 12% below the 200-day average ($232) — a downtrend. 36% below the 52-week high of $318, 11% above the 52-week low of $185.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $204.46 is currently inside the band (band $196–$252).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 39.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently below its signal line by 1.95, negative momentum.
Relative performance vs S&P 500 & its sector (XLE (sector)), set to 100 a year ago
Solid = FSLR · dashed = S&P 500 · dotted = XLE (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What it is
First Solar, Inc. (Nasdaq: FSLR) is a Tempe/Phoenix-Arizona-based photovoltaic (PV) manufacturer founded in 1999. It designs and makes cadmium-telluride (CdTe) thin-film solar modules — a fundamentally different technology from the crystalline-silicon panels that dominate the global market and that are overwhelmingly Chinese-supplied. That distinction is the whole strategic point: First Solar is "the only U.S.-headquartered company among the world's largest solar manufacturers" and its product is "independent from Chinese crystalline silicon supply chains" (management's own words, Q1'26 release). Customers are utilities, independent power producers, and commercial/industrial developers. Fiscal year ends December 31. CEO is Mark R. Widmar; ~8,100 employees.
Revenue mix (FY2025, from filings):
- By product: essentially a pure-play module business — the FMP product segmentation reports a single "Solar Module" line (~$15B tag is a data artifact; the FY24 breakout shows "Modules Segment" $4.20B vs "Other" $3.6M). Treat FSLR as a one-product company: it sells solar modules.
- By geography (FY2025): United States $4.99B (~96%) · India $196M · France $6M. The revenue base is now overwhelmingly US-concentrated — a deliberate pivot (US was only 67% in FY2023, and as recently as FY2010 the US was a minority of sales behind Germany). This is a bet on the US Inflation Reduction Act / domestic-content buildout, and it is both the growth engine and the concentration risk.
The strategic story is simple and honest: US policy (IRA, as amended by the "One Big Beautiful Bill Act of 2025") pays domestic manufacturers via the Section 45X advanced-manufacturing tax credit, and First Solar — as the US thin-film champion insulated from Chinese supply — is the prime beneficiary. That is the tailwind and the single point of failure (§11).
2. The expert thesis — why the panel is bullish (traceable)
There is no expert coverage of FSLR in the Synthos knowledge base. total_claims = 0, net-bullish voices = 0, and the top claim list is empty. We will not manufacture conviction we do not have: no claim_id values exist to cite, and none appear below.
That means this note is explicitly a fundamentals- and quant-driven call. The bull/base/bear and the three scores in §3 are built entirely from the reported financials, the analyst-estimate consensus (labeled as estimates), the technical block, and management's own SEC-filed guidance (half-weighted, §9). Readers who weight our conviction names by expert breadth should note this name has breadth 0 — treat the verdict accordingly (Tactical, small size), not as a high-conviction Core call.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 6 · Moderate-High | Offsetting forces: 14.5× trailing EPS and net cash (net-debt/EBITDA −0.84×) are genuinely safe, but beta 1.7, deep industry cyclicality, and ~$2.1B of Section 45X credits (~40% of guided EBITDA) that Washington controls push risk up. |
| Growth Quality | 7 · Good | ~14% forward EPS CAGR, 42% gross / 31% net margin, 18% ROE, 15% ROIC, 47.9 GW backlog. Real — but a chunk of margin is subsidy, and it's a commodity module, so not a 9. |
| Exponential Potential | 5 · Moderate | Large, real US-solar TAM and a policy tailwind, but a cyclical commodity-module maker at a policy inflection is not a compounding platform. Growth decelerates after the FY26-27 subsidy-driven step-up. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | 45X credits preserved and extended; US domestic-content demand accelerates; backlog converts at full price; margins hold ~40%. FY27E EPS beats toward ~$28 (vs $24.1 cons); the market re-rates a de-risked policy story to ~14×. | ~$400 (+78%) |
| Base (our anchor) | Guidance roughly holds; 45X intact at current terms; FY27E EPS ~$24; a cyclical-but-cash-rich compounder earns a modest ~11× (still a discount to the market for cyclicality/policy risk). | ~$260 (+16%) |
| Bear | 45X credit cut, capped, or made harder to monetize; solar oversupply / ASP pressure; a US-demand air-pocket. FY26-27 EPS resets toward ~$13-15; multiple de-rates to ~9× on a lower, subsidy-light earnings base. | ~$130 (−42%) |
Synthos fair value = the base case, ~$260 (+16%), with the full $130–$400 span as the honest range. This anchor sits essentially on top of the Street's $255 consensus — we are not claiming an edge over the sell side here, because with zero expert coverage we defer more to the estimate consensus than we would on a high-breadth name. Note the range is wide and skewed by one policy variable (45X): that asymmetry, not the midpoint, is the real story. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). FSLR is neither a serene compounder nor a clean exponential — it is a cyclical manufacturer riding a policy-driven demand wave:
- Forward growth: revenue CAGR FY25→FY30E ~6% ($5.22B → $6.97B); EPS CAGR ~14% ($14.25 → $27.03) as fixed-cost leverage and 45X credits expand margins. Note the EPS path grows far faster than revenue — that gap is the operating leverage and the subsidy, and it's the fragile part.
- Acceleration (the 2nd derivative) is front-loaded, then negative: EPS jumps +24% (FY26E) → +36% (FY27E) as new capacity ramps, then decelerates toward the high-single digits (FY28E +20%, FY29-30E flattening). The steep leg is the 2026-27 US-capacity/45X inflection; from there it's a cyclical, not a secular, ramp.
- Room to run: the US solar TAM is large and the domestic-content buildout is real, so demand runway exists. But at $24B this is already a mid-cap, and the binding constraint isn't market size — it's cyclicality and policy (module ASPs, oversupply, subsidy terms). A commodity manufacturer does not command a platform multiple.
- Reinvestment runway: heavy, productive capex (South Carolina finishing facility, US fabs) — but capex is falling in guidance ($0.8-1.0B FY26 vs $1.53B FY24 build peak), so FCF has already inflected sharply positive (+$1.19B FY25 vs −$0.31B FY24). The buildout hump is largely behind it — good for cash, but it also means the growth-capex story is maturing.
Exponential Potential: Moderate (5). Own it for a cheap, cash-generative cyclical with a real (but policy-dependent) US tailwind — not for durable exponential compounding. A subsidy-levered commodity module maker is structurally capped below the platform/software names that earn 8-9 here.
5. Financials (real numbers — FMP annual/quarterly)
- Revenue: FY25 $5.22B, +24.1% (FY24 $4.21B, +26.7% on FY23 $3.32B). Solid, sustained top-line growth off the US buildout.
- Quarterly trajectory: Q1'25 $845M → Q2 $1.10B → Q3 $1.59B → Q4 $1.68B → Q1'26 $1.04B (+23.6% YoY). Note the heavy seasonality — Q1 is always the low quarter (module delivery cadence), so the sequential Q4→Q1 drop is normal, not deterioration.
- Margins: gross 41.7% TTM (40.6% FY25), operating ~33%, net 30.7% TTM. Margins have expanded dramatically from the FY22 trough (gross margin was 2.7% in FY22, when the company posted a small net loss). That swing is the tell: this is a cyclical whose margins move violently — and the current high margins bake in 45X credits.
- Earnings: net income $1.53B FY25 (+18% on FY24 $1.29B); diluted EPS $14.21 vs $12.02. FY22 was a −$0.41 EPS loss — a reminder of the downside amplitude. Q1'26 EPS $3.22 (+65% YoY) beat the $3.03 estimate.
- Cash flow: operating CF $2.06B FY25, capex −$0.87B, FCF +$1.19B — a sharp inflection from negative FCF in FY23 (−$0.78B) and FY24 (−$0.31B) as the capex hump rolls off. This positive-FCF turn is the single most important financial development — watch that it sustains.
- Balance sheet: cash & ST investments $2.86B, total debt only $499M → net cash ~$2.3B (net-debt/EBITDA −0.84×). Current ratio 2.6×, debt/equity 0.04×. A genuine fortress — this is what caps the downside and earns the "Buy" over "Watch."
6. Valuation — priced in or room?
On the trailing numbers FSLR is cheap in absolute and relative terms: 14.5× EPS, 4.1× EV/sales, 9.6× EV/EBITDA, 2.4× book, and net-cash-adjusted even cheaper. PEG is ~0.46 on TTM growth. On live consensus the forward P/E falls every year — 12.7× (FY26E) → 9.3× (FY27E) → 8.3× (FY30E) — so if estimates hit, an investor is paying single-digit forward earnings for a growing, net-cash US manufacturer. The FMP letter rating is B+ (ROE score 5/5, ROA 5/5), though its DCF sub-score is a cautious 1/5.
The bear's rebuttal is the honest one: these multiples are cheap because the market is discounting the durability of the earnings. A meaningful slice of EBITDA is the Section 45X credit ($2.10-2.19B assumed in 2026 guidance against $2.6-2.8B Adjusted EBITDA — i.e. roughly 40% of guided EBITDA is a tax credit). Strip or haircut that, and the "9× EV/EBITDA" is really a higher multiple on subsidy-light earnings. So the cheapness is real but conditional. Street targets (context): consensus $255, high $315, low $205 — our $260 base FV sits right on consensus, reflecting that with no proprietary expert edge here we defer to the estimate crowd. Cheap, yes; risk-free cheap, no.
7. Technicals (from the tech block)
- Trend: down. $224.6 sits below the 50-DMA ($245) and the 200-DMA ($235), and the 50 is below the 200 — a death-cross / downtrend posture. MACD −6.7 (negative).
- Location: −29.4% off the 52-week high ($318), +39.6% off the 52-week low ($161); max drawdown from peak −29.4%. This is a name that has already corrected hard.
- Momentum: RSI(14) 21.8 — deeply oversold (<30). Historically a mean-reversion setup, and the core reason we call this Tactical rather than "wait": you're buying weakness, not chasing strength.
- Relative strength (mixed): despite the drawdown, FSLR is still +37.8% over 12 months vs SPY +20.6% and QQQ +30.3% — leadership over a year. But −15.0% over 6 months vs SPY +8.4% — sharp recent underperformance. The 3-month has turned back up (+12.6% vs SPY +13.7%).
- Read: technicals conflict with the cheap fundamentals in the short term — a broken trend but a washed-out, oversold RSI. This is a classic "cheap and hated" setup: attractive for a tactical entry with a plan to scale, dangerous for anyone who needs the trend to already be up. A reclaim of the 200-DMA (~$235) would confirm the turn.
8. Moat & competitive position
First Solar's moat is narrow but real and unusually policy-shaped:
1. Differentiated technology — CdTe thin-film is proprietary and structurally not dependent on the Chinese crystalline-silicon supply chain that commoditizes the rest of the industry. That is a genuine, defensible technical/geopolitical edge.
2. Domestic-content advantage — as the leading US-headquartered manufacturer, FSLR is the natural winner of IRA/45X domestic-content incentives; competitors face tariffs and trade remedies it is insulated from.
3. Contracted backlog — a 47.9 GW contracted sales backlog (as of 2026-03-31) gives multi-year revenue visibility rare for a manufacturer.
The limits: it still sells a commodity output (electricity-generating modules) into a globally oversupplied market where Chinese crystalline-silicon capacity sets the price ceiling, and the whole domestic-content edge is a creature of policy rather than pure product superiority.
Peer set (from FMP — note: this list is FMP's generic "Energy" sector bucket, NOT solar pure-plays): Cheniere Energy Partners $29.7B, Cenovus $46.0B, EQT $32.9B, Expand Energy $21.7B, Halliburton $27.5B, Nextpower $17.0B, Pembina $27.0B, Targa Resources $55.6B, Woodside $37.0B. These are LNG/oil/gas/pipeline names — not true comparables. FSLR's real competitors are Chinese crystalline-silicon makers (LONGi, JinkoSolar, Trina, JA Solar) and US peers like Nextpower ($17.0B). Read the peer table as "energy sector context," not as a valuation comp set.
9. Management, capital allocation & guidance
- Capital allocation: disciplined and self-funded — heavy US-fab capex now rolling off ($0.8-1.0B guided FY26 vs $1.53B FY24 peak), no dividend, minimal buyback ($15.5M FY25, essentially just offsetting dilution), and a net-cash balance sheet. Appropriate for a cyclical: keep dry powder, don't lever into the cycle.
- Insider activity: the most recent Form 4s (filed 2026-07-01) are routine director equity awards (223-share grants) plus one tiny in-kind tax withholding — no meaningful open-market selling or buying signal in the sampled window. Neutral.
- Management's own guidance (SEC 8-K, half-weighted — they talk their book): in the Q1'26 release (filed 2026-04-30) management reaffirmed full-year 2026 guidance: Volume sold 17.0-18.2 GW, Net sales $4.9-5.2B, Gross profit $2.4-2.6B, Operating expenses $610-635M, Adjusted EBITDA $2.6-2.8B, Capex $0.8-1.0B, year-end net cash $1.7-2.3B. Critically, that Adjusted-EBITDA guide "assumes $2.10 billion to $2.19 billion of Section 45X tax credits" — management itself confirms the subsidy is ~40% of EBITDA. For Q2'26 they guide 3.4-4.0 GW shipped and $400-500M Adjusted EBITDA. This is real, dated, self-interested guidance and we weight it accordingly (half-weight): it corroborates the growth and explicitly flags the policy dependency.
10. Catalysts & what to watch
- Next earnings: 2026-07-30 (Q2'26; Street EPS $2.85, revenue ~$1.06B; management guides $400-500M Adjusted EBITDA and 3.4-4.0 GW shipped). Key line: 45X credit realization and module ASPs.
- US policy (the dominant catalyst): any legislative or regulatory change to Section 45X / IRA domestic-content rules under the "One Big Beautiful Bill Act of 2025" framework. This dwarfs company-specific news.
- Bookings & backlog: additions to (or slippage in) the 47.9 GW contracted backlog — the visibility metric.
- FCF durability: confirmation the +$1.19B FY25 free-cash-flow inflection sustains as capex rolls off.
- Trade/tariff actions: changes to tariffs or trade remedies against Chinese crystalline-silicon imports (a tailwind if tightened, a headwind if loosened).
Thesis tripwires (what would change the call): a cut or cap to Section 45X; two consecutive quarters of module-ASP / gross-margin compression; backlog cancellations; or FCF slipping back to negative as a new capex cycle starts.
11. Key risks
- Policy / subsidy risk (structural, dominant): ~$2.1B of Section 45X tax credits ≈ 40% of guided 2026 Adjusted EBITDA. Any reduction, cap, or monetization friction hits earnings directly. Management's own guidance is explicitly conditioned on "the current U.S. policy environment persists." This is the single biggest risk and the reason for Tactical, not Core.
- Deep cyclicality: beta 1.7; the company posted a net loss in FY22 with 2.7% gross margins. Solar module pricing is a global commodity set by oversupplied Chinese capacity; margins can swing violently.
- Customer / geographic concentration: ~96% of revenue is US and the customer base is a concentrated set of utility/IPP developers — project delays or a US demand air-pocket flow straight through.
- Technical downtrend: below both key moving averages with a death-cross posture; being cheap has not stopped it falling 29%.
- NO expert corroboration: unlike our conviction names, there is zero KB coverage — no independent expert panel is validating this thesis. Lower confidence by construction.
12. Verdict, position sizing & monitoring
Buy — Tactical. FSLR is a genuinely cheap (14.5× trailing, single-digit forward P/E), net-cash ($2.3B), FCF-positive US manufacturing champion with a 47.9 GW backlog, expanding margins, 18% ROE, and management reaffirming a $2.6-2.8B EBITDA guide — bought here at a deeply oversold RSI of 22, 29% off its high. That's an attractive mean-reversion setup. But the earnings lean ~40% on a government subsidy, the stock is a high-beta cyclical in a broken short-term trend, and — critically — there is no expert coverage in our KB to corroborate a higher-conviction call. So we buy it as a trade, sized small.
- Sizing: tactical / satellite, ~1-3% — a cyclical mean-reversion position, not a core compounder. Given the downtrend, scale in (starter now, adds on a 200-DMA reclaim or further washout toward the low-$200s / high-$100s) rather than a lump.
- Monitoring: re-underwrite on the §10 tripwires — above all any 45X policy change. Formal re-score each earnings print. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $224.57.
- Single biggest risk: the Section 45X tax credit — a Washington policy line that is ~40% of guided EBITDA; the whole valuation math changes if it changes.
Provenance & disclosures
- Traceability: 0 KB claims, breadth 0 — there is no expert coverage of FSLR in the Synthos knowledge base, so no
claim_idvalues are cited. This is a fundamentals- and quant-driven note; fabricated conviction is structurally impossible (nothing to reconcile against, and none claimed). - Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · management guidance from the SEC 8-K filed 2026-04-30. Forward figures are analyst consensus (FMP) or management guidance, each labeled as estimates.
- Management caveat: the 2026 guidance in §9 is management's own SEC-filed words, half-weighted by design (they talk their book); it explicitly conditions Adjusted-EBITDA guidance on ~$2.1B of Section 45X credits.
- Peer caveat: the FMP peer list is a generic "Energy" sector bucket (LNG/oil/gas), not solar comparables; treat it as sector context only.
- Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
- Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").